The Association Between Uterine Artery Notch and First Trimester Bleeding

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Soroka University Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Gali Pariente, Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT01069406
First received: February 15, 2010
Last updated: June 20, 2012
Last verified: June 2012
  Purpose

The purpose of the present study is to evaluate the occurrence of first trimester bleeding among patients with abnormal uterine artery Doppler.

A prospective study is designed and two groups will be studied; patients with abnormal uterine artery Doppler at second trimester (study group) and patient with normal uterine artery Doppler at second trimester (control group).The patients will be asked, as part of the routine history taken before the US about having first trimester bleeding during the current pregnancy.


Condition
Uterine Artery Notch
First Trimester Bleeding

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Association Between Uterine Artery Notch and First Trimester Bleeding

Further study details as provided by Soroka University Medical Center:

Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
presence of uterine artery notch
patients with uterine artery notch during the 2nd and 3rd trimester

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

patients with abnormal uterine artery Doppler at second trimester. pregnant women with eather: elevated HCG and/or aFP at triple test, patients with history of pre eclampsia, IUGR, APD, and patients with thrombophilia.

Criteria

Inclusion Criteria:

  • Patients with abnormal uterine artery Doppler at second trimester

Exclusion Criteria:

  • Multi fetal pregnancies
  • Patients without known gestational age (according to last month period or first trimester ultrasound
  • Pregnancies with congenital structural or chromosomal anomalies
  • Lack of prenatal care
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01069406

Contacts
Contact: Gali Pariente, MD galipa@bgu.ac.il

Locations
Israel
Us unit Recruiting
Soroka medical center, Beer sheva, Israel
Contact: Relika Hershkovitz, MD         
Principal Investigator: Gali Pariente, MD         
Sponsors and Collaborators
Soroka University Medical Center
  More Information

No publications provided

Responsible Party: Gali Pariente, Dr, Soroka University Medical Center
ClinicalTrials.gov Identifier: NCT01069406     History of Changes
Other Study ID Numbers: sor493710CTIL
Study First Received: February 15, 2010
Last Updated: June 20, 2012
Health Authority: Israel: Clalit Health Services

Keywords provided by Soroka University Medical Center:
notch
uterine
first
bleeding

Additional relevant MeSH terms:
Hemorrhage
Pathologic Processes

ClinicalTrials.gov processed this record on July 20, 2014